Compugen (CGEN) Interest Expenses (2011 - 2025)
Compugen (CGEN) reported Interest Expenses of $55.7 million for Q4 2025, down 49.31% on a YoY basis from $109.8 million in Q4 2024, and down 49.31% sequentially from $109.8 million in Q4 2024.
Compugen (CGEN) Interest Expenses (2011 - 2025) Analysis & Trends
Compugen (CGEN) has 15 years of Interest Expenses data on file, last reported at $55.7 million in Q4 2025.
- For the quarter ending Q4 2025, Interest Expenses fell 49.31% year-over-year to $55.7 million; the trailing twelve-month figure through Dec 2025 stood at $55.7 million (down 49.31% YoY), and the FY2025 full-year result was $55.7 million, down 49.31% from the prior year.
- Interest Expenses declined to $55.7 million in Q4 2025, from $109.8 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $109.8 million in Q4 2024 to a low of $1.9 million in Q4 2023.
- A 5-year average of $55.5 million and a median of $55.7 million in 2025 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses sank 98.21% in 2023 and soared 5643.41% in 2024, its largest moves.
- Tracing CGEN's Interest Expenses over 5 years: stood at $3.3 million in 2021, then jumped by 3118.21% to $106.9 million in 2022, then slumped by 98.21% to $1.9 million in 2023, then soared by 5643.41% to $109.8 million in 2024, then plunged by 49.31% to $55.7 million in 2025.
- Business Quant data shows CGEN's Interest Expenses at $55.7 million in Q4 2025, $109.8 million in Q4 2024, and $1.9 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Compugen | 215.59 Mn | 123.84 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55.67 Mn |
| Dec 31, 2025 | 55.67 Mn |
| Dec 31, 2024 | 109.81 Mn |
| Dec 31, 2024 | 109.81 Mn |
| Dec 31, 2023 | 1.91 Mn |
| Dec 31, 2023 | 1.91 Mn |
| Dec 31, 2022 | 106.94 Mn |
| Dec 31, 2022 | 106.94 Mn |
| Dec 31, 2021 | 3.32 Mn |
| Dec 31, 2021 | 3.32 Mn |
| Dec 31, 2020 | 37.59 Mn |
| Dec 31, 2020 | 37.59 Mn |
| Dec 31, 2019 | 13.94 Mn |
| Dec 31, 2019 | 13.94 Mn |
| Dec 31, 2018 | 69.11 Mn |
| Dec 31, 2018 | 69.11 Mn |
| Dec 31, 2017 | 64.22 Mn |
| Dec 31, 2017 | 64.22 Mn |
| Dec 31, 2016 | 56.98 Mn |
| Dec 31, 2016 | 56.98 Mn |